Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950123-10-051131
Filing Date
2010-05-19
Accepted
2010-05-19 11:19:36
Documents
6
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A c01380e10vkza.htm 10-K/A 690862
2 EXHIBIT 23.1 c01380exv23w1.htm EX-23.1 1582
3 EXHIBIT 31.1 c01380exv31w1.htm EX-31.1 7597
4 EXHIBIT 31.2 c01380exv31w2.htm EX-31.2 7643
5 EXHIBIT 32.1 c01380exv32w1.htm EX-32.1 3037
6 EXHIBIT 32.2 c01380exv32w2.htm EX-32.2 3131
  Complete submission text file 0000950123-10-051131.txt   715403
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-50626 | Film No.: 10844455
SIC: 2834 Pharmaceutical Preparations